Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients

R. Fogari, A. Zoppi, G. D. Malamani, G. Marasi, A. Vanasia, G. Villa

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

1. In order to evaluate whether treatment with different antihypertensive drugs would affect plasma fibrinogen levels, 118 mild to moderate essential hypertensive subjects, all males, aged 18 to 65 years, were randomly treated with amlodipine 10 mg, atenolol 100 mg, hydrochlorothiazide 25 mg or lisinopril 20 mg, all given once daily for 8 weeks. 2. Before and after 8 weeks' treatment, blood pressure (BP), heart rate (HR), fibrinogen, total cholesterol (TC), HDL-C, LDL-C, triglycerides (TG), plasma glucose, plasma uric acid, serum creatinine and serum potassium were evaluated. 3. All four medications significantly reduced BP values, although the BP lowering effect of lisinopril, amlodipine and atenolol was significantly greater compared with that of hydrochlorothiazide. 4. Plasma fibrinogen levels were unaffected by atenolol, hydrochlorothiazide and amlodipine, whereas they were significantly decreased by lisinopril (-11.2%, P = 0.002). This fibrinogen lowering effect was more evident in smokers (-17.7%) than in non smokers (-7.4%). 5. Atenolol and amlodipine did not significantly affect plasma lipids, hydrochlorothiazide increased TC, LDL-C and TG and reduced HDL-C; lisinopril increased HDL-C and decreased TC and LDL-C. 6. Hydrochlorothiazide increased plasma glucose and uric acid concentrations, which were unaffected by the other drugs. The diuretic also reduced serum potassium. 7. The results of this study indicate that lisinopril reduces levels of plasma fibrinogen and confirm that different antihypertensive drugs may elicit different metabolic effects, which may variously influence the overall risk profile of the hypertensive patients.

Original languageEnglish
Pages (from-to)471-476
Number of pages6
JournalBritish Journal of Clinical Pharmacology
Volume39
Issue number5
Publication statusPublished - 1995

Fingerprint

Lisinopril
Fibrinogen
Antihypertensive Agents
Hydrochlorothiazide
Amlodipine
Atenolol
Blood Pressure
Uric Acid
Potassium
Serum
Glucose
Diuretics
LDL Cholesterol
HDL Cholesterol
Creatinine
Heart Rate
Cholesterol
Lipids
Therapeutics
Pharmaceutical Preparations

Keywords

  • Amlodipine
  • Atenolol
  • Fibrinogen
  • Hydrochlorothiazide
  • Hypertension
  • Lisinopril

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Fogari, R., Zoppi, A., Malamani, G. D., Marasi, G., Vanasia, A., & Villa, G. (1995). Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients. British Journal of Clinical Pharmacology, 39(5), 471-476.

Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients. / Fogari, R.; Zoppi, A.; Malamani, G. D.; Marasi, G.; Vanasia, A.; Villa, G.

In: British Journal of Clinical Pharmacology, Vol. 39, No. 5, 1995, p. 471-476.

Research output: Contribution to journalArticle

Fogari, R, Zoppi, A, Malamani, GD, Marasi, G, Vanasia, A & Villa, G 1995, 'Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients', British Journal of Clinical Pharmacology, vol. 39, no. 5, pp. 471-476.
Fogari, R. ; Zoppi, A. ; Malamani, G. D. ; Marasi, G. ; Vanasia, A. ; Villa, G. / Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients. In: British Journal of Clinical Pharmacology. 1995 ; Vol. 39, No. 5. pp. 471-476.
@article{052ea567385f429ba9a7ae6ddab7c2c3,
title = "Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients",
abstract = "1. In order to evaluate whether treatment with different antihypertensive drugs would affect plasma fibrinogen levels, 118 mild to moderate essential hypertensive subjects, all males, aged 18 to 65 years, were randomly treated with amlodipine 10 mg, atenolol 100 mg, hydrochlorothiazide 25 mg or lisinopril 20 mg, all given once daily for 8 weeks. 2. Before and after 8 weeks' treatment, blood pressure (BP), heart rate (HR), fibrinogen, total cholesterol (TC), HDL-C, LDL-C, triglycerides (TG), plasma glucose, plasma uric acid, serum creatinine and serum potassium were evaluated. 3. All four medications significantly reduced BP values, although the BP lowering effect of lisinopril, amlodipine and atenolol was significantly greater compared with that of hydrochlorothiazide. 4. Plasma fibrinogen levels were unaffected by atenolol, hydrochlorothiazide and amlodipine, whereas they were significantly decreased by lisinopril (-11.2{\%}, P = 0.002). This fibrinogen lowering effect was more evident in smokers (-17.7{\%}) than in non smokers (-7.4{\%}). 5. Atenolol and amlodipine did not significantly affect plasma lipids, hydrochlorothiazide increased TC, LDL-C and TG and reduced HDL-C; lisinopril increased HDL-C and decreased TC and LDL-C. 6. Hydrochlorothiazide increased plasma glucose and uric acid concentrations, which were unaffected by the other drugs. The diuretic also reduced serum potassium. 7. The results of this study indicate that lisinopril reduces levels of plasma fibrinogen and confirm that different antihypertensive drugs may elicit different metabolic effects, which may variously influence the overall risk profile of the hypertensive patients.",
keywords = "Amlodipine, Atenolol, Fibrinogen, Hydrochlorothiazide, Hypertension, Lisinopril",
author = "R. Fogari and A. Zoppi and Malamani, {G. D.} and G. Marasi and A. Vanasia and G. Villa",
year = "1995",
language = "English",
volume = "39",
pages = "471--476",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients

AU - Fogari, R.

AU - Zoppi, A.

AU - Malamani, G. D.

AU - Marasi, G.

AU - Vanasia, A.

AU - Villa, G.

PY - 1995

Y1 - 1995

N2 - 1. In order to evaluate whether treatment with different antihypertensive drugs would affect plasma fibrinogen levels, 118 mild to moderate essential hypertensive subjects, all males, aged 18 to 65 years, were randomly treated with amlodipine 10 mg, atenolol 100 mg, hydrochlorothiazide 25 mg or lisinopril 20 mg, all given once daily for 8 weeks. 2. Before and after 8 weeks' treatment, blood pressure (BP), heart rate (HR), fibrinogen, total cholesterol (TC), HDL-C, LDL-C, triglycerides (TG), plasma glucose, plasma uric acid, serum creatinine and serum potassium were evaluated. 3. All four medications significantly reduced BP values, although the BP lowering effect of lisinopril, amlodipine and atenolol was significantly greater compared with that of hydrochlorothiazide. 4. Plasma fibrinogen levels were unaffected by atenolol, hydrochlorothiazide and amlodipine, whereas they were significantly decreased by lisinopril (-11.2%, P = 0.002). This fibrinogen lowering effect was more evident in smokers (-17.7%) than in non smokers (-7.4%). 5. Atenolol and amlodipine did not significantly affect plasma lipids, hydrochlorothiazide increased TC, LDL-C and TG and reduced HDL-C; lisinopril increased HDL-C and decreased TC and LDL-C. 6. Hydrochlorothiazide increased plasma glucose and uric acid concentrations, which were unaffected by the other drugs. The diuretic also reduced serum potassium. 7. The results of this study indicate that lisinopril reduces levels of plasma fibrinogen and confirm that different antihypertensive drugs may elicit different metabolic effects, which may variously influence the overall risk profile of the hypertensive patients.

AB - 1. In order to evaluate whether treatment with different antihypertensive drugs would affect plasma fibrinogen levels, 118 mild to moderate essential hypertensive subjects, all males, aged 18 to 65 years, were randomly treated with amlodipine 10 mg, atenolol 100 mg, hydrochlorothiazide 25 mg or lisinopril 20 mg, all given once daily for 8 weeks. 2. Before and after 8 weeks' treatment, blood pressure (BP), heart rate (HR), fibrinogen, total cholesterol (TC), HDL-C, LDL-C, triglycerides (TG), plasma glucose, plasma uric acid, serum creatinine and serum potassium were evaluated. 3. All four medications significantly reduced BP values, although the BP lowering effect of lisinopril, amlodipine and atenolol was significantly greater compared with that of hydrochlorothiazide. 4. Plasma fibrinogen levels were unaffected by atenolol, hydrochlorothiazide and amlodipine, whereas they were significantly decreased by lisinopril (-11.2%, P = 0.002). This fibrinogen lowering effect was more evident in smokers (-17.7%) than in non smokers (-7.4%). 5. Atenolol and amlodipine did not significantly affect plasma lipids, hydrochlorothiazide increased TC, LDL-C and TG and reduced HDL-C; lisinopril increased HDL-C and decreased TC and LDL-C. 6. Hydrochlorothiazide increased plasma glucose and uric acid concentrations, which were unaffected by the other drugs. The diuretic also reduced serum potassium. 7. The results of this study indicate that lisinopril reduces levels of plasma fibrinogen and confirm that different antihypertensive drugs may elicit different metabolic effects, which may variously influence the overall risk profile of the hypertensive patients.

KW - Amlodipine

KW - Atenolol

KW - Fibrinogen

KW - Hydrochlorothiazide

KW - Hypertension

KW - Lisinopril

UR - http://www.scopus.com/inward/record.url?scp=0029032666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029032666&partnerID=8YFLogxK

M3 - Article

C2 - 7669481

AN - SCOPUS:0029032666

VL - 39

SP - 471

EP - 476

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 5

ER -